Literature DB >> 30145979

[Acute heart failure].

Mattia Arrigo1, Frank Ruschitzka1, Andreas J Flammer1.   

Abstract

Acute heart failure Abstract. Acute heart failure (AHF) is a life-threatening condition requiring immediate treatment. The initial therapy should take into account the clinical presentation, the pathophysiology at play, the precipitating factors, and the underlying cardiac pathology. Particular attention should be given to polymorbidity and the avoidance of potential iatrogenic harms. Patient preferences and ethical issues should be integrated into the treatment plan at an early stage. The average survival of AHF patients is two years and the most vulnerable period is the three-month time window directly after discharge. Therefore, reducing both persistent subclinical congestion and underutilization of disease-modifying heart failure therapies as well as ensuring optimal transitions of care after hospital discharge are essentials in improving outcomes of AHF patients.

Entities:  

Mesh:

Year:  2018        PMID: 30145979     DOI: 10.1024/0040-5930/a000980

Source DB:  PubMed          Journal:  Ther Umsch        ISSN: 0040-5930


  5 in total

1.  Efficacy of urapidil for the treatment of patients with senile hypertension and acute heart failure.

Authors:  Yan-Zhong Xie; Jian-Ming Ni; Shan-Jing Zhang; Guo-Rong Ding; Jun-Fei Feng
Journal:  Medicine (Baltimore)       Date:  2019-10       Impact factor: 1.817

2.  Value of PTEN and Echocardiography in Predicting the Efficacy of Trimetazidine Combined with Metoprolol in the Treatment of Heart Failure.

Authors:  Xue-Hong Feng; Yang Wang; Lian-Yu Wang; Jun-Fei Shen; Chun-Yuan You; Qiu-Ting Feng
Journal:  Int J Gen Med       Date:  2021-12-23

3.  Cardioprotective Effect of Paeonol on Chronic Heart Failure Induced by Doxorubicin via Regulating the miR-21-5p/S-Phase Kinase-Associated Protein 2 Axis.

Authors:  Cong Chen; Shuhong Liu; Gaozhen Cao; Yang Hu; Run Wang; Min Wu; Mingya Liu; Kai Hang Yiu
Journal:  Front Cardiovasc Med       Date:  2022-07-05

4.  The Relationship between Angiotensin-Neprilysin Treatment, Echocardiographic Parameters, and NT-proBNP Levels in HFpEF Patients with Acute Decompensated Heart Failure.

Authors:  Xiaoliang Zhang; Song Yang; Zhonglin Xu
Journal:  Comput Math Methods Med       Date:  2022-09-12       Impact factor: 2.809

5.  Efficacy and safety of spironolactone for the treatment of patients with acute heart failure: A protocol for systematic review.

Authors:  Yan-Lin Feng; Min Lu
Journal:  Medicine (Baltimore)       Date:  2020-10-23       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.